Search - tctmd.com

Displaying 61 - 80 of 150

Sort: Relevancy | Date

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Daily News

‘These Are Good Organs’: Drug Overdose Deaths Boost Transplants, With Few Downsides

Todd Neale

June 10, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Daily News

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

Michael O'Riordan

May 02, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

News Daily News

Patients Retain Little From Cath Lab Informed-Consent Conversations

Michael O'Riordan

April 26, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

L.A. McKeown

March 15, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

Yael L. Maxwell

November 01, 2018

News Opinion Off Script TCT 2018

Off Script: Sharing, Caring, and Daring to Dream

Kwan S. Lee

September 22, 2018

News Daily News

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Todd Neale

July 18, 2018

News Daily News

Open Questions: Cardiology Editors and Academics Mull Data-Sharing Pitfalls and Potential

Shelley Wood

July 04, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

News Conference News SCAI 2018

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

L.A. McKeown

May 04, 2018

News Conference News SCAI 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

L.A. McKeown

April 26, 2018

News Daily News

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

L.A. McKeown

February 15, 2018

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

Advertisement

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

‘These Are Good Organs’: Drug Overdose Deaths Boost Transplants, With Few Downsides

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

TCTMD’s Top 10 Most Popular Stories for April 2019

Patients Retain Little From Cath Lab Informed-Consent Conversations

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

Off Script: Sharing, Caring, and Daring to Dream

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Open Questions: Cardiology Editors and Academics Mull Data-Sharing Pitfalls and Potential

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content